Kathleen C. Torkko, Ph.D.

Affiliations: 
2005 University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
Area:
General, Medicine and Surgery, Oncology, Pathology, Genetics
Google:
"Kathleen Torkko"

Parents

Sign in to add mentor
John Hokanson grad student 2005 University of Colorado, Denver
 (Vitamin D receptor gene polymorphisms and prostate cancer.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Jillson LK, Rider LC, Rodrigues LU, et al. (2021) Loss Drives Enhanced Androgen Signaling and Independently Confers Risk of Recurrence in Prostate Cancer with Joint Loss of . Molecular Cancer Research : McR
Torkko K, Till C, Tangen CM, et al. (2020) Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial. Cancer Prevention Research (Philadelphia, Pa.)
Panigrahi GK, Praharaj PP, Kittaka H, et al. (2019) Exosome proteomic analyses identify inflammatory phenotype and novel biomarkers in African American prostate cancer patients. Cancer Medicine
Kessler ER, Su LJ, Gao D, et al. (2018) Phase II Trial of Acai Juice Product in Biochemically Recurrent Prostate Cancer. Integrative Cancer Therapies. 1534735418803755
Greene LI, Bruno TC, Christenson JL, et al. (2018) A Role for Tryptophan-2,3-dioxygenase in CD8 T Cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma. Molecular Cancer Research : McR
Gordon MA, D'Amato NC, Gu H, et al. (2017) Synergy between androgen receptor antagonism and inhibition of mTOR and HER2 in breast cancer. Molecular Cancer Therapeutics
Miles FL, Goodman PJ, Tangen C, et al. (2017) Interactions of the Insulin-Like Growth Factor Axis and Vitamin D in Prostate Cancer Risk in the Prostate Cancer Prevention Trial. Nutrients. 9
Deep G, Panigrahi G, Singh R, et al. (2017) Abstract B11: Proteomic analysis of serum-derived exosomes: Identification of novel protein signature associated with African-American prostate cancer Cancer Epidemiology, Biomarkers & Prevention. 26
D'Amato NC, Gordon MA, Babbs B, et al. (2016) Cooperative Dynamics of AR and ER Activity in Breast Cancer. Molecular Cancer Research : McR
Gari HH, Gearheart CM, Fosmire S, et al. (2016) Genome-wide functional genetic screen with the anticancer agent AMPI-109 identifies PRL-3 as an oncogenic driver in triple-negative breast cancers. Oncotarget
See more...